口服小剂量阿司匹林对冠心病患者血清脂蛋白(a)的影响(2)
 |
| 第1页 |
参见附件。
[2] 张丽霞,孙艳虹,孙芹敏等.血小板血栓形成过程中之蛋白(a)作用的研究.中华检验医学杂志,2001,24:8-11.
[3] 郝一文,孙胜玫,张丽霞等,脑血管病急性脑梗死患者脂蛋白(a)与血小板蛋白激酶C的变化.中华脑血管病医学杂志,2000,19:95-97.
[4] Komai N,Morishita R,Yamada S,et al.Mitogenic activity of oxidized lipoprotein (a)on human vascular smooth muscle cells.Hypertension,2002,40:310-314.
[5] 潘满东,卢伟.脂蛋白(a)与脑血管病相关性研究进展.脑与神经疾病杂志,2006,14:80-81.
[6] Cerrato P,Imperiale D,Fornengo P ,et al.Higher Lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease . Neurology, 2002,58:653-655.
[7] Arenillas J F, Molina C A,Chacon P, et al. Higher Lipoprotein (a) diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology,2004,63:27-32.
[8] Carlson LA.Nicotinic acid: the borad -spectrumlipid drug.A 50th anniversary review. J Intern Med, 2005,258:94-114.
[9] Torbus-lisiecka B,Bukowska H,Jastrzebska M,et al.Lp(a), homocysteine and a family history of early ischemic cerebral stroke .Nutr Metab Cardiovasc Dis ,2001,5:52-59.
[10] Kagawa A, Azuma H,Akaike M, et al. Aspirin reduces apolipoprotein (a) production in human hepatocytes by suppression of Apo(a) gene transcription. J Biol Chem, 1999,274:34111-34115.
[11] Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin .Science,1994,265:956-995.
[12] Akaike M, Azuma H,Kagawa A,et al.Effect of Aspirin treatment on serum concerntrations of lipoprotein (a) in patients with atherosclerotic diseases. Clinical Chem,2002,48:1454-1459.
[13] 张华,张茁 小剂量阿司匹林对脑血管病患者血清脂蛋白(a)的作用.北京医学,2008,2:65-67.
您现在查看是摘要介绍页，详见PDF附件。